Customized research for DMAC vs. FNAM!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for DMAC vs. FNAM.


↗ Join Our Free Email Newsletter.




Diamedica Therapeutics Inc. vs. Fona, Inc.

Industry Match! Industry of Both DMAC and FNAM:

Health Care/Life Sciences

DMAC
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: N/A (Update Now!)


P/E: N/A

P/S: N/A

Q P/B: N/A

Y Rev: 500,000

Q Rev: -

Beta: N/A

DMAC Share Stats

Outstanding Shares

11.96M

Float Shares

116.05M

Percent of Float Short

0.01%

DMAC Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

DMAC Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

DMAC in Pulse Portal

Stream of Posts

DMAC Symbol Page

Share DMAC Insights

Express Sentiment

'Buy' or 'Sell' DMAC

DMAC Profile

CEO

Mr. Rick John Pauls

Exchange

Nasdaq

Employees

9.00

About

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). The company was founded...

DMAC Financials

Annual Financials

Income Statement

Revenue

500,000

Net Income

(5.73M)

Cash Flow Statement

Change in Cash / Investments

15.47M

Balance Sheet

Cash / Investments

16.82M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

17.97M

Total Current Liabilities

1.3M

Total Assets

18.34M

Total Liabilities

1.31M

Stockholder Equity

17.03M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(3.25M)

Cash Flow Statement

Q Change in Cash / Investments

(14.06M)

Balance Sheet

Q Cash / Investments

13.72M

Q Short Term Debt

49,000

Q Long Term Debt

None

Q Total Current Assets

14.94M

Q Total Current Liabilities

1.43M

Q Total Assets

15.49M

Q Total Liabilities

1.59M

Q Stockholder Equity

13.91M

DMAC Charts

10-Year Chart

DMAC 10-Year Chart

5-Year Chart

DMAC 5-Year Chart

1-Year Chart

DMAC 1-Year Chart

6-Month Chart

DMAC 6-Month Chart

3-Month Chart

DMAC 3-Month Chart

1-Month Chart

DMAC 1-Month Chart

1-Day Chart

DMAC 1-Day Chart

FNAM
Data Last Updated: 2 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 11.47M


P/E: N/A

P/S: 104.27

Q P/B: 3.18

Y Rev: 114,814

Q Rev: 50,753

Beta: -0.23

FNAM Share Stats

Outstanding Shares

5.88M

Float Shares

3.64M

Percent of Float Short

N/A

FNAM Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

FNAM Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FNAM in Pulse Portal

Stream of Posts

FNAM Symbol Page

Share FNAM Insights

Express Sentiment

'Buy' or 'Sell' FNAM

FNAM Profile

CEO

Dr. Walter Messier

Exchange

OTC

Employees

4.00

About

Evolutionary Genomics, Inc. engages in developing and marketing an interactive information and advertising service. Its gene portfolio includes soybean pest and disease resistance, tomato sweetness and salt tolerance, cotton project, rice yield, wheat stern rust resistance,...

FNAM Financials

Annual Financials

Income Statement

Revenue

114,814

Net Income

(1.1M)

Cash Flow Statement

Change in Cash / Investments

(748,837)

Balance Sheet

Cash / Investments

159,606

Short Term Debt

None

Long Term Debt

None

Total Current Assets

223,417

Total Current Liabilities

-

Total Assets

4.41M

Total Liabilities

971,903

Stockholder Equity

3.43M

Quarterly Financials

Income Statement

Q Revenue

50,753

Q Net Income

(181,745)

Cash Flow Statement

Q Change in Cash / Investments

337,651

Balance Sheet

Q Cash / Investments

374,678

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

444,428

Q Total Current Liabilities

20,936

Q Total Assets

4.59M

Q Total Liabilities

976,382

Q Stockholder Equity

3.61M

FNAM Charts

10-Year Chart

FNAM 10-Year Chart

5-Year Chart

FNAM 5-Year Chart

1-Year Chart

FNAM 1-Year Chart

6-Month Chart

FNAM 6-Month Chart

3-Month Chart

FNAM 3-Month Chart

1-Month Chart

FNAM 1-Month Chart

1-Day Chart

FNAM 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon